EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor budding in preoperative breast biopsies predicts sentinel lymph node metastasis

Songul Peltek Ozer, Bahri Ozer, Gulali Aktas

Biomolecules and Biomedicine · 07.11.2025 · 26 (4) · 662-667

DOI: 10.17305/bb.2025.13323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 07.11.2025. Verfasst von Songul Peltek Ozer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Abant Izzet Baysal University Hospital, Bolu, Türkiye. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma, Ductal, Breast, Sentinel Lymph Node. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sentinel lymph node biopsy (SLNB) is a pivotal technique employed to assess the necessity for axillary lymph node dissection (ALND), evaluated during the preoperative phase through clinical and radiological findings. The preoperative identification of sentinel lymph node metastasis has gained paramount importance in the surgical management of breast cancer. Tumor budding (TB) has emerged as a significant prognostic marker across various cancers, including breast cancer, where it is instrumental in detecting lymph node metastasis. This study aims to investigate the role of tumor budding in predicting sentinel lymph node metastasis in preoperative breast biopsies. We included patients diagnosed with breast cancer, specifically those with invasive ductal carcinoma (IDC), who underwent preoperative needle biopsy and subsequent evaluation of postoperative surgical specimens, as well as SLNB at our medical center. The histological slides of these cases were reevaluated, and tumor cell clusters comprising up to four cells were classified as TB. Lymph nodes exhibiting tumor cell involvement, limited to macrometastasis, were classified as positive. A total of 65 patients were enrolled in the study. Among these, 36 patients exhibited TB in their preoperative biopsies, while 29 did not. The median tumor sizes were 20 mm (range: 6–50 mm) in the TB-positive group and 19 mm (range: 2–50 mm) in the TB-negative group (p=0.3). Sentinel lymph node metastasis was detected in 18 patients with TB, compared to only five patients without TB, a difference that was statistically significant (p=0.006). We conclude that evaluating tumor budding in breast tru-cut specimens, in conjunction with clinical and radiological findings, may enhance the preoperative assessment of breast cancer cases requiring SLNB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCarcinoma, Ductal, BreastSentinel Lymph NodeHumansFemaleSentinel Lymph Node BiopsyLymphatic MetastasisMiddle AgedAgedAdultPreoperative CarePreoperative Period

Autor:innen und Institutionen

  • Department of Pathology, Abant Izzet Baysal University Hospital, Bolu, Türkiye.
  • Department of General Surgery, Abant Izzet Baysal University Hospital, Bolu, Türkiye.
  • Department of Internal Medicine, Abant Izzet Baysal University Hospital, Bolu, Türkiye.

Zitieren

APA

Ozer, S. P., Ozer, B., & Aktas, G. (2025). Tumor budding in preoperative breast biopsies predicts sentinel lymph node metastasis. Biomolecules and Biomedicine, 26(4), 662-667. https://doi.org/10.17305/bb.2025.13323

Vancouver

Ozer SP, Ozer B, Aktas G. Tumor budding in preoperative breast biopsies predicts sentinel lymph node metastasis. Biomolecules and Biomedicine. 2025;26(4):662-667. doi:10.17305/bb.2025.13323

BibTeX
@article{Ozer2025,
  author = {Ozer, Songul Peltek and Ozer, Bahri and Aktas, Gulali},
  title = {Tumor budding in preoperative breast biopsies predicts sentinel lymph node metastasis},
  journal = {Biomolecules and Biomedicine},
  year = {2025},
  volume = {26},
  number = {4},
  pages = {662--667},
  doi = {10.17305/bb.2025.13323}
}
Kostenlos starten →